| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.01 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.01 |